Zobrazeno 1 - 10
of 126
pro vyhledávání: '"C. Kontogiannis"'
Autor:
A Simistiras, D Delialis, G Georgiopoulos, D Bampatsias, E Maneta, A Dimoula, I Petropoulos, O Neofytou, E Oikonomou, C Kontogiannis, S Ioannou, A Miliotou, I Kanakakis, E Evangelou, K Stamatelopoulos
Publikováno v:
European Heart Journal. 43
Background Deeper understanding of the potential causal relationship between Lp(a) and vascular injury will provide further insight to related pathways to be monitored and targeted by emerging treatments. Accumulating evidence supports the causal ass
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Z Akhtar, M Sohal, C Kontogiannis, LWM Leung, I Harding, Z Zuberi, A Bajpai, M Norman, S Pearse, I Beeton, MM Gallagher
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background Cardiac resynchronisation therapy (CRT) is the cornerstone of heart failure management. Delivery of a left ventricular lead can occur in a small proportion of patients undermining the
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background Transvenous lead extraction (TLE) has become an important strategy in the management of patients with cardiac implantable electronic devices (CIEDs). A rising population of patients w
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background Tunnelled dialysis catheters are integral to the management of patients with chronic kidney disease (CKD), providing a means to dialysis. They are prone to blockages necessitating rem
Autor:
M, Spartalis, G, Siasos, M, Mastrogeorgiou, E, Spartalis, V V, Kaminiotis, K S, Mylonas, A, Kapelouzou, C, Kontogiannis, I P, Doulamis, K, Toutouzas, N, Nikiteas, D C, Iliopoulos
Publikováno v:
European review for medical and pharmacological sciences. 25(24)
Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome. Colchicine is an anti-inflammatory agent that inhibits inflammasome's action
Autor:
K, Tampakis, N, Vogiatzakis, C, Kontogiannis, M, Spartalis, A, Ntalianis, E, Spartalis, I, Siafaka, N, Iacovidou, A, Chalkias, T, Xanthos
Publikováno v:
European review for medical and pharmacological sciences. 24(12)
Intravenous lipid emulsions (ILE) were developed many decades ago to supply nutritional requirements to patients unable to obtain adequate enteral nutrition. The utility of ILE was extended to therapeutics, facilitating the delivery of drugs. More re
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S, Makris, K, Venetsanou, E, Spartalis, C, Kontogiannis, G, Georgiopoulos, M, Spartalis, D I, Tsilimigras, D, Moris, I, Kakisis, G, Karaolanis, N, Patelis, V, Zymvragoudakis, T I, Papasilekas, K M, Themistoklis, A, Lazaris
Publikováno v:
European review for medical and pharmacological sciences. 23(5)
Leptin is an adipokine, known to be associated with oxidative stress, inflammation, and atherogenesis. Leptin plays an essential role in atheromatosis-associated inflammatory cascade through stimulation of inflammatory mediators such as soluble intra
Autor:
M, Spartalis, E, Spartalis, E, Tzatzaki, D I, Tsilimigras, D, Moris, C, Kontogiannis, D C, Iliopoulos, V, Voudris, G, Siasos
Publikováno v:
European review for medical and pharmacological sciences. 23(1)
Cardiac allograft vasculopathy (CAV) is a leading cause of mortality in heart transplantation patients. Despite optimal immunosuppression therapy, the rate of CAV post-transplantation remains high. In this review, we gathered all recent studies as we